Board Member
Xenon Pharmaceuticals Inc. (XENE)Chief Accounting Officer
Xenon Pharmaceuticals Inc. (XENE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Recorded current and former roles; source labels appear when available.
2025-06-30–present
Recorded roles and earnings-call appearances connecting this person to public companies.
CEO, Board Member, CFO, Chief Accounting Officer
2025-06-30–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Xenon Pharmaceuticals Inc. (XENE) | President and Chief Executive Officer | $786,000 | $9,221,712 |
| 2024 | Xenon Pharmaceuticals Inc. (XENE) | President and Chief Executive Officer | $714,589 | $9,795,347 |
| 2023 | Xenon Pharmaceuticals Inc. (XENE) | President and Chief Executive Officer | $666,018 | $10,117,829 |
| 2022 | Xenon Pharmaceuticals Inc. (XENE) | President and Chief Executive Officer | $594,669 | $9,228,604 |
| 2021 | Xenon Pharmaceuticals Inc. (XENE) | President and Chief Executive Officer | $524,297 | $3,894,997 |
| 2020 | Xenon Pharmaceuticals Inc. (XENE) | President and Chief Executive Officer | $461,970 | $1,783,084 |
| 2019 | Xenon Pharmaceuticals Inc. (XENE) | President and Chief Executive Officer | $420,861 | $1,553,382 |
| 2018 | Xenon Pharmaceuticals Inc. (XENE) | President and Chief Financial Officer | $342,492 | $922,681 |
Earnings-call appearances and filed executive appointments or departures, newest first.
